Arkolith/Insider Trading/NAUT/Form 4

Godwin Mary E.

Senior VP, OperationsNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed Sep 25, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$135K
Net Open-Market Flow
-$135K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 23, 2024Option exercise(M)47K$0.46$22K47K
Sep 23, 2024Sell(S)47K$2.87$135K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 23, 2024Option exercise(M)47K—$0353K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808805-24-000067) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML